METHYL 4,4-DIFLUOROPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE, 95.0%, 250mg

H-Hyp-OH, 97%, 25g

Oxo-piperazin-1-yl-acetic acid, 98.0%, 10g

4-(6-Bromopyridin-3-yl)morpholine, 95.0%, 5g

2-(3-Chloro-4-methylphenoxy)acetic acid, 95%, 250mg

5-Aminonicotinonitrile, 95.0%, 25g

2-Chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 97%, 250mg

3-(4-Methylpiperazin-1-yl)benzaldehyde, 95.0%, 25g

Polyethylene Glycol Monostearate (n=approx. 2) (palmitate and stearate mixture)25g

Bis(4-fluorophenyl)iodonium triflate, 98%, 1g

Long working distance plan 4x/0.13 IOS objective, corrected for 1 mm thickness

Pyrazolo[1,5-a]pyridine-3-carbonitrile, 96%, 1g

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-{[(propan-2-yl)[(1r,3s)-3-[2-(6-tert-butyl-1H-1,3-benzodiazol-2-yl)ethyl]cyclobutyl]amino]methyl}oxolane-3,4-diol, 99.99%, 10mg